Plain-English summary
Court vacates Fifth Circuit and affirms FDA decisions denying new e‑cigarette market applications
The Supreme Court unanimously vacated the Fifth Circuit’s decision and remanded, holding that the lower court wrongly rejected the Food and Drug Administration’s denials of applications to market new e‑cigarette products. The FDA’s authority to require and deny premarket authorization under the Tobacco Control Act was sustained.
Why this matters
The decision confirms the FDA’s ability to apply the statutory standard and to deny market authorization for new tobacco products, including e‑cigarettes, when it finds the evidence insufficient to show the products meet the statutory requirements. That preserves the agency’s role in evaluating public‑health risks and prevents lower courts from substituting their judgment for the agency’s reasoned decisionmaking.
Who may feel it
- E‑cigarette and other new tobacco product manufacturers and distributors
- Retailers who sell vaping products
- Consumers, especially youth and smokers considering switching to vaping
- Public‑health agencies and advocacy groups
- FDA regulators and administrative law practitioners